Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report) shares reached a new 52-week high during trading on Friday . The stock traded as high as $14.04 and last traded at $14.00, with a volume of 1016597 shares changing hands. The stock had previously closed at $13.38.
Silverback Therapeutics Trading Up 4.6 %
The company has a market capitalization of $504.81 million, a PE ratio of -5.53 and a beta of 0.60. The firm has a 50 day simple moving average of $14.62 and a two-hundred day simple moving average of $11.79.
About Silverback Therapeutics
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
See Also
- Five stocks we like better than Silverback Therapeutics
- The Significance of Brokerage Rankings in Stock Selection
- Tesla Investors Continue to Profit From the Trump Trade
- What is a SEC Filing?
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- 5 Top Rated Dividend Stocks to Consider
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg?v=20230224062438&h=45&w=95&zc=2){kind=logo}
